Leadership changes, September 2026
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes
1,052
Appointments
619
Departures
64
Browse by role
September 2026
Get new CFO appointments the day the filing lands.
Filters
1,052 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | House of Doge Inc. | Stephen Ilott | DirectorDirector | Appointed | Jun 30, 2026 | SEC 8-K |
| Sep 14, 2026 | House of Doge Inc. | Duncan Moir | DirectorDirector | Appointed | Jun 30, 2026 | SEC 8-K |
| Sep 14, 2026 | House of Doge Inc. | Rene Rodriguez | Acting Chief Financial OfficerCFO | Departed | Jun 30, 2026 | SEC 8-K |
| Sep 14, 2026 | House of Doge Inc. | Marco Margiotta | Chief Executive OfficerCEO | Appointed | Jun 30, 2026 | SEC 8-K |
| Sep 14, 2026 | House of Doge Inc. | Charles Park | Chief Financial OfficerCFO | Appointed | Jun 30, 2026 | SEC 8-K |
| Sep 14, 2026 | House of Doge Inc. | Timothy Stebbing | Chief Technology OfficerCTO | Departed | Aug 31, 2026 | SEC 8-K |
| Sep 14, 2026 | House of Doge Inc. | Stephen Ilott | DirectorDirector | Departed | Jul 19, 2026 | SEC 8-K |
| Sep 14, 2026 | INGLES MARKETS INC | Kevin Hefner | directordirector | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 14, 2026 | Inmune Bio, Inc. | R. Duane Clark II | directordirector | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 14, 2026 | Inmune Bio, Inc. | James Sapirstein | directordirector | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 14, 2026 | INSEEGO CORP. | Stephen Bye | Board of DirectorsBoard of Directors | Departed | Sep 30, 2026 | SEC 8-K |
| Sep 14, 2026 | INSEEGO CORP. | Stephen Bye | Chief Executive OfficerCEO | Appointed | n/a | SEC 8-K |
| Sep 14, 2026 | I-ON Digital Corp. | Kenneth Park | DirectorDirector | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 14, 2026 | IRulya Therapeutics Inc. | Charles Ryan | PresidentPresident | Departed | Sep 8, 2026 | SEC 8-K |
| Sep 14, 2026 | lululemon athletica inc. | Heidi O’Neill | Class II directorClass II director | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 14, 2026 | National Healthcare Properties, Inc. | Edward M. Weil, Jr. | board of directorsboard of directors | Departed | Sep 11, 2026 | SEC 8-K |
| Sep 14, 2026 | NPK International Inc. | James Barton | Executive Vice President, Commercial Growth & OperationsExecutive Vice President, Commercial Growth & Operations | Appointed | Sep 22, 2026 | SEC 8-K |
| Sep 14, 2026 | PDS Biotechnology Corp | Patrick Soon-Shiong | Class C directorClass C director | Appointed | Sep 14, 2026 | SEC 8-K |
| Sep 14, 2026 | PDS Biotechnology Corp | James Banaag | Class A directorClass A director | Appointed | Sep 14, 2026 | SEC 8-K |
| Sep 14, 2026 | Rainmaker Worldwide Inc. | Michael O’Connor | directordirector | Departed | Sep 10, 2026 | SEC 8-K |
- House of Doge Inc.Appointed
Stephen Ilott Director
Filed Sep 14, 2026Effective Jun 30, 2026SEC 8-K
- House of Doge Inc.Appointed
Duncan Moir Director
Filed Sep 14, 2026Effective Jun 30, 2026SEC 8-K
- House of Doge Inc.Departed
Rene Rodriguez CFO
Filed Sep 14, 2026Effective Jun 30, 2026SEC 8-K
- House of Doge Inc.Appointed
Marco Margiotta CEO
Filed Sep 14, 2026Effective Jun 30, 2026SEC 8-K
- House of Doge Inc.Appointed
Charles Park CFO
Filed Sep 14, 2026Effective Jun 30, 2026SEC 8-K
- House of Doge Inc.Departed
Timothy Stebbing CTO
Filed Sep 14, 2026Effective Aug 31, 2026SEC 8-K
- House of Doge Inc.Departed
Stephen Ilott Director
Filed Sep 14, 2026Effective Jul 19, 2026SEC 8-K
- INGLES MARKETS INCAppointed
Kevin Hefner director
Filed Sep 14, 2026Effective Sep 8, 2026SEC 8-K
- Inmune Bio, Inc.Appointed
R. Duane Clark II director
Filed Sep 14, 2026Effective Sep 8, 2026SEC 8-K
- Inmune Bio, Inc.Appointed
James Sapirstein director
Filed Sep 14, 2026Effective Sep 8, 2026SEC 8-K
- INSEEGO CORP.Departed
Stephen Bye Board of Directors
Filed Sep 14, 2026Effective Sep 30, 2026SEC 8-K
- INSEEGO CORP.Appointed
Stephen Bye CEO
Filed Sep 14, 2026SEC 8-K
- I-ON Digital Corp.Departed
Kenneth Park Director
Filed Sep 14, 2026Effective Sep 8, 2026SEC 8-K
- IRulya Therapeutics Inc.Departed
Charles Ryan President
Filed Sep 14, 2026Effective Sep 8, 2026SEC 8-K
- lululemon athletica inc.Appointed
Heidi O’Neill Class II director
Filed Sep 14, 2026Effective Sep 8, 2026SEC 8-K
Edward M. Weil, Jr. board of directors
Filed Sep 14, 2026Effective Sep 11, 2026SEC 8-K
- NPK International Inc.Appointed
James Barton Executive Vice President, Commercial Growth & Operations
Filed Sep 14, 2026Effective Sep 22, 2026SEC 8-K
- PDS Biotechnology CorpAppointed
Patrick Soon-Shiong Class C director
Filed Sep 14, 2026Effective Sep 14, 2026SEC 8-K
- PDS Biotechnology CorpAppointed
James Banaag Class A director
Filed Sep 14, 2026Effective Sep 14, 2026SEC 8-K
- Rainmaker Worldwide Inc.Departed
Michael O’Connor director
Filed Sep 14, 2026Effective Sep 10, 2026SEC 8-K